5.13. Analysis.
Comparison 5 Rivastigmine 5 cm2 patch (4.6 mg/day) versus placebo, Outcome 13 at least one adverse event application site exfoliation by 24 weeks.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.